These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31736256)

  • 1. Are population-based patient-reported outcomes associated with overall survival in patients with advanced pancreatic cancer?
    Dai WF; Beca J; Guo H; Isaranawatchai W; Schwartz D; Naipaul R; Arias J; Qiao Y; Gavura S; Redmond-Misner R; Ismail Z; Barbera L; Chan K
    Cancer Med; 2020 Jan; 9(1):215-224. PubMed ID: 31736256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Baseline Edmonton Symptom Assessment Scale Scores on Treatment and Survival in Patients With Advanced Non-small-cell Lung Cancer.
    McGee SF; Zhang T; Jonker H; Laurie SA; Goss G; Nicholas G; Albaimani K; Wheatley-Price P
    Clin Lung Cancer; 2018 Jan; 19(1):e91-e99. PubMed ID: 28666762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating Patient-Reported Outcomes Into Prognostication in Gastroesophageal Cancer: Results of a Population-Based Retrospective Cohort Analysis.
    Baccili Cury Megid T; Sharma D; Baskurt Z; Xiaolu Ma L; Wang X; Barron CC; Jang RW; Chen EX; Swallow CJ; Mesci A; Yeung J; Wong RKS; Brar SS; Veit-Haibach P; Kim J; Bach Y; Aoyama H; Elimova E
    Oncologist; 2024 Apr; 29(4):316-323. PubMed ID: 38431782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of routine Edmonton Symptom Assessment System (ESAS) use on overall survival in cancer patients: Results of a population-based retrospective matched cohort analysis.
    Barbera L; Sutradhar R; Seow H; Mittmann N; Howell D; Earle CC; Li Q; Thiruchelvam D
    Cancer Med; 2020 Oct; 9(19):7107-7115. PubMed ID: 32794634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-Reported Symptoms for Esophageal Cancer Patients Undergoing Curative Intent Treatment.
    Gupta V; Allen-Ayodabo C; Davis L; Zhao H; Hallet J; Mahar AL; Ringash J; Kidane B; Darling G; Coburn NG
    Ann Thorac Surg; 2020 Feb; 109(2):367-374. PubMed ID: 31550465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptom Burden of Patients with Advanced Pancreas Cancer (APC): A Provincial Cancer Institute Observational Study.
    Lelond S; Ward J; Lambert PJ; Kim CA
    Curr Oncol; 2021 Jul; 28(4):2789-2800. PubMed ID: 34436010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of the revised Edmonton Symptom Assessment System (ESAS-r) and the Patient-Reported Functional Status (PRFS) in lung cancer patients.
    Yogananda MN; Muthu V; Prasad KT; Kohli A; Behera D; Singh N
    Support Care Cancer; 2018 Mar; 26(3):767-775. PubMed ID: 29027005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptom Burden in Patients With Reduced Performance Status at the Start of Palliative Radiotherapy.
    Nieder C; Kämpe TA
    In Vivo; 2020; 34(2):735-738. PubMed ID: 32111778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Preoperative Patient-Reported Symptoms and Postoperative Outcomes in Rectal Cancer Patients: A Retrospective Cohort Study.
    Bubis LD; Coburn NG; Sutradhar R; Gupta V; Jeong Y; Davis LE; Mahar AL; Karanicolas PJ
    J Surg Res; 2021 Mar; 259():86-96. PubMed ID: 33279848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Province-Wide Analysis of Patient-Reported Outcomes for Stage IV Non-Small Cell Lung Cancer.
    Tjong MC; Doherty M; Tan H; Chan WC; Zhao H; Hallet J; Darling G; Kidane B; Wright FC; Mahar A; Davis LE; Delibasic V; Parmar A; Mittmann N; Coburn NG; Louie AV
    Oncologist; 2021 Oct; 26(10):e1800-e1811. PubMed ID: 34216415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncology Nurses' Attitudes Toward the Edmonton Symptom Assessment System: Results From a Large Cancer Care Ontario Study.
    Green E; Yuen D; Chasen M; Amernic H; Shabestari O; Brundage M; Krzyzanowska MK; Klinger C; Ismail Z; Pereira J
    Oncol Nurs Forum; 2017 Jan; 44(1):116-125. PubMed ID: 27991609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with patient-reported subjective well-being among advanced lung or non-colonic gastrointestinal cancer patients.
    Yennurajalingam S; Kim YJ; Zhang Y; Park J; Arthur J; Chisholm GB; Williams JL; Bruera E
    Palliat Support Care; 2018 Feb; 16(1):23-31. PubMed ID: 28264748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of automated screening with Edmonton Symptom Assessment System (ESAS) on health-related quality of life, supportive care needs, and patient satisfaction with care in 268 ambulatory cancer patients.
    Diplock BD; McGarragle KMC; Mueller WA; Haddad S; Ehrlich R; Yoon DA; Cao X; Al-Allaq Y; Karanicolas P; Fitch MI; Myers J; Mitchell AJ; Ellis JWM
    Support Care Cancer; 2019 Jan; 27(1):209-218. PubMed ID: 29931490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-screening of patient-reported symptoms using the Edmonton Symptom Assessment System in outpatient palliative cancer care.
    Lee G; Kim HS; Lee SW; Park YR; Kim EH; Lee B; Hu YJ; Kim KA; Kim D; Cho HY; Kang B; Choi HJ
    Eur J Cancer Care (Engl); 2020 Nov; 29(6):e13305. PubMed ID: 33016473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptom Burden of Nonresected Pancreatic Adenocarcinoma: An Analysis of 10,753 Patient-Reported Outcome Assessments.
    Mavros MN; Davis LE; Hallet J; Tung S; Mahar AL; Bubis LD; Hammad A; Zhao H; Earle CC; Barbera L; Coburn NG
    Pancreas; 2020 Sep; 49(8):1083-1089. PubMed ID: 32769858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world outcomes of FOLFIRINOX vs gemcitabine and nab-paclitaxel in advanced pancreatic cancer: A population-based propensity score-weighted analysis.
    Chan KKW; Guo H; Cheng S; Beca JM; Redmond-Misner R; Isaranuwatchai W; Qiao L; Earle C; Berry SR; Biagi JJ; Welch S; Meyers BM; Mittmann N; Coburn N; Arias J; Schwartz D; Dai WF; Gavura S; McLeod R; Kennedy ED
    Cancer Med; 2020 Jan; 9(1):160-169. PubMed ID: 31724340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of symptom screening on survival among patients with cancer across varying levels of pre-diagnosis psychiatric care.
    Sutradhar R; Li Q; Kurdyak P; Barbera L
    Cancer Med; 2022 Feb; 11(3):838-846. PubMed ID: 34931479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptom Evolution in Patients with Esophageal and Gastric Cancer Receiving Palliative Chemotherapy: A Population-Based Study.
    Merchant SJ; Kong W; Brundage M; Booth CM
    Ann Surg Oncol; 2021 Jan; 28(1):79-87. PubMed ID: 33140252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe symptoms persist for Up to one year after diagnosis of stage I-III lung cancer: An analysis of province-wide patient reported outcomes.
    Hirpara DH; Gupta V; Davis LE; Zhao H; Hallet J; Mahar AL; Sutradhar R; Doherty M; Louie AV; Kidane B; Darling G; Coburn NG
    Lung Cancer; 2020 Apr; 142():80-89. PubMed ID: 32120228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of physical and psychological symptom burden with time to death among palliative cancer outpatients.
    Cheung WY; Barmala N; Zarinehbaf S; Rodin G; Le LW; Zimmermann C
    J Pain Symptom Manage; 2009 Mar; 37(3):297-304. PubMed ID: 18694634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.